| pubmed-article:9972139 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9972139 | lifeskim:mentions | umls-concept:C1123023 | lld:lifeskim |
| pubmed-article:9972139 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:9972139 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:9972139 | lifeskim:mentions | umls-concept:C0043240 | lld:lifeskim |
| pubmed-article:9972139 | lifeskim:mentions | umls-concept:C0038432 | lld:lifeskim |
| pubmed-article:9972139 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:9972139 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:9972139 | lifeskim:mentions | umls-concept:C0763143 | lld:lifeskim |
| pubmed-article:9972139 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9972139 | pubmed:dateCreated | 1999-2-18 | lld:pubmed |
| pubmed-article:9972139 | pubmed:abstractText | Delayed wound healing is one of the complications of diabetes mellitus, exhibited by increased wound collagenase and decreased granulation tissues. The current study compared wound healing in normal and diabetic rats, and the effects of topically applied 1% or 3% concentrations of chemically modified tetracycline-2 (CMT-2) on 6-mm circular full-thickness skin wounds healed by secondary intention. On day 7 after wounding, tissues were removed for biochemical analysis and histology. The wound granulation tissue hydroxyproline was less in the untreated diabetic rat with increased collagenase and gelatinase. Treating the diabetic rat wounds with 3% CMT-2 increased the wound hydroxyproline and decreased activities of gelatinase and collagenase. There was a delay in wound filling by granulation tissue in diabetic rats. In CMT-2-treated diabetic rats, the volume of granulation tissue was greater than that in untreated diabetic rats. CMT-2 appears to normalize wound healing in diabetic rats and may be a valuable adjunct in the treatment of chronic wounds. | lld:pubmed |
| pubmed-article:9972139 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9972139 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9972139 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9972139 | pubmed:citationSubset | D | lld:pubmed |
| pubmed-article:9972139 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9972139 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9972139 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9972139 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9972139 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9972139 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9972139 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:9972139 | pubmed:issn | 0895-9374 | lld:pubmed |
| pubmed-article:9972139 | pubmed:author | pubmed-author:GolubL MLM | lld:pubmed |
| pubmed-article:9972139 | pubmed:author | pubmed-author:RamamurthyN... | lld:pubmed |
| pubmed-article:9972139 | pubmed:author | pubmed-author:McNamaraT FTF | lld:pubmed |
| pubmed-article:9972139 | pubmed:author | pubmed-author:McClainS ASA | lld:pubmed |
| pubmed-article:9972139 | pubmed:author | pubmed-author:KucineA JAJ | lld:pubmed |
| pubmed-article:9972139 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9972139 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:9972139 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9972139 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9972139 | pubmed:pagination | 144-8 | lld:pubmed |
| pubmed-article:9972139 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:meshHeading | pubmed-meshheading:9972139-... | lld:pubmed |
| pubmed-article:9972139 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9972139 | pubmed:articleTitle | Topically applied CMT-2 enhances wound healing in streptozotocin diabetic rat skin. | lld:pubmed |
| pubmed-article:9972139 | pubmed:affiliation | Department of Oral Biology and Pathology, School of Dental Medicine, Stony Brook, New York 11794-8702, USA. | lld:pubmed |
| pubmed-article:9972139 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9972139 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9972139 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
